Folic acid supplementation and methotrexate therapy for psoriasis

Journal of the American Academy of Dermatology

Volumn 55, Issue 2, 2006, Pages 366-367

  Hughes, Rosalind ^a   Harries, Matthew ^b   Chalmers, Robert J ^b   Kirby, Brian ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE;

ADD ON THERAPY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; FOLIC ACID DEFICIENCY; HUMAN; LETTER; LIVER FIBROSIS; LUNG TOXICITY; PANCYTOPENIA; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

DERMATOLOGIC AGENTS; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; METHOTREXATE; PSORIASIS;

EID: 33745855136     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.01.072     Document Type: Letter

References (6)

1. Strober B., and Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol 53 (2005) 652-659
2. Boffa M.J., and Chalmers R.J.G. Methotrexate for psoriasis. Clin Exp Dermatol 21 (1996) 399-408
3. Salaffi F., Manganelli P., Subiaco S., Lamanna G., and Cervini C. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature. Clin Rheumatol 16 (1997) 296-304
4. West S.G. Methotrexate hepatotoxicity. Rheum Dis Clin 23 (1997) 883-917
5. Kirby B., Lyon C., Griffiths C., and Chalmers R. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom. Clin Exp Dermatol 25 (2000) 265-268
6. Landewe R., van den Borne B., Breedveld F., and Dikjmans B. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular morbidity. Lancet 355 (2000) 1616-1617